An official website of the United States government Here's how you know

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 077109
Company: COSETTE

Products on ANDA 077109

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
HALOBETASOL PROPIONATE	HALOBETASOL PROPIONATE	0.05%	OINTMENT;TOPICAL	Prescription	AB	No	No

Approval Date(s) and History, Letters, Labels, Reviews for ANDA 077109

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
06/14/2005	ORIG-1	Approval				Label is not available on this site.

Therapeutic Equivalents for ANDA 077109

HALOBETASOL PROPIONATE

OINTMENT;TOPICAL; 0.05%
TE Code = AB

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
HALOBETASOL PROPIONATE	HALOBETASOL PROPIONATE	0.05%	OINTMENT;TOPICAL	Prescription	No	AB	077109	COSETTE
HALOBETASOL PROPIONATE	HALOBETASOL PROPIONATE	0.05%	OINTMENT;TOPICAL	Prescription	No	AB	076872	PADAGIS ISRAEL
HALOBETASOL PROPIONATE	HALOBETASOL PROPIONATE	0.05%	OINTMENT;TOPICAL	Prescription	No	AB	213560	QUAGEN
HALOBETASOL PROPIONATE	HALOBETASOL PROPIONATE	0.05%	OINTMENT;TOPICAL	Prescription	No	AB	076994	TARO

Top